Miltenyi Biotec

MHC MACSimer A*0201 KRAS-G12V (KLVVVGAVGV), human, Vio667

#130-135-297 · western blot

200
Citing papers
54.8k
Combined citations
Supplier page Find this product

Research areas

Immune cells in cancer50Cancer Immunotherapy and Biomarkers40Cancer Cells and Metastasis33Immune Cell Function and Interaction30CAR-T cell therapy research26Immunotherapy and Immune Responses21Pancreatic and Hepatic Oncology Research17Cancer Genomics and Diagnostics16

Papers citing this product

1
Inferring tumour purity and stromal and immune cell admixture from expression data
Nature Communications·2013·10.7k cit.·DOI
2
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
The Journal of Experimental Medicine·2017·2.4k cit.·DOI
3
Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
Nature·2023·1.2k cit.·DOI
4
Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
Nature Communications·2014·986 cit.·DOI
5
PERK is required at the ER-mitochondrial contact sites to convey apoptosis after ROS-based ER stress
Cell Death and Differentiation·2012·832 cit.·DOI
6
Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells.
The Journal of Experimental Medicine·1996·755 cit.·DOI
7
CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity
Immunity·2020·749 cit.·DOI
8
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party
Blood·2021·704 cit.·DOI
9
Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer
The Journal of Experimental Medicine·2011·691 cit.·DOI
10
Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma
Nature Communications·2020·670 cit.·DOI

Also available from other vendors

This target has 755 citing papers across all vendors combined

VendorProductPricePapers
LSBio (LifeSpan)Monoclonal Mouse anti‑Human KRAS Antibody (clone 2C1)$45913
Santa Cruz BiotechnologyKRAS Antibody (B-12)—200
Miltenyi BiotecMHC MACSimer A*0201 KRAS-G12V (KLVVVGAVGV), human, Vio667—5
Miltenyi BiotecMHC MACSimer A*0201 KRAS-G12V (KLVVVGAVGV), human, PE—200
Miltenyi BiotecMHC MACSimer A*0201 KRAS-G12V (KLVVVGAVGV), human, PE—1
MedChemExpressKRAS Antibody (YA6861)—200
NovusKRAS Antibody (OTI2C1) [DyLight 405]—200
Santa Cruz BiotechnologyKRAS Antibody (3B10-2F2)—1
NovusKRAS Antibody (OTI2C1) [DyLight 350]—200

Similar products

ProductVendorPricePapers
MHC MACSimer A*0201 KRAS-G12V (KLVVVGAVGV), human, Vio667Miltenyi Biotec—5